Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 06.03. FARMACOS QUE AFECTAN EL METABOLISMO DE LOS LIPIDOS | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 12.6. Lipid-lowering agents |
Others observations: For use in high-risk patients. This medicine has the best evidence for effectiveness and safety. |
| Haiti. National List of Essential Medicines | 12.06. Hypolipidemics | No observations |
| Bahamas. Drug Formulary | 02. CARDIOVASCULAR DRUGS | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 12.6. Lipid-lowering agents |
Others observations: For use in high-risk patients. This medicine has the best evidence for effectiveness and safety. |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 1.11.2 Statins | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | C. APARELHO CARDIOVASCULAR | No observations |
| Haiti. National List of Essential Medicines | 12.06. Hypolipidemics | No observations |
| Bahamas. Drug Formulary | 02. CARDIOVASCULAR DRUGS | No observations |
| Belize. National Drug Formulary | 12.06 Lipid-lowering agents | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 12.6. Lipid-lowering agents |
Others observations: For use in high-risk patients. This medicine has the best evidence for effectiveness and safety. |
| Peru | 12.6 Hypolipidemiants | No observations |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 1.11.2 Statins | No observations |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 05. ENDOCRINOLOGIA Y METABOLISMO | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | C. APARELHO CARDIOVASCULAR | No observations |
| Suriname. NGK-C-011 | 12.6 Lipid Lowering Agents | No observations |
| Haiti. National List of Essential Medicines | 12.06. Hypolipidemics | No observations |
| Bahamas. Drug Formulary | 02. CARDIOVASCULAR DRUGS | No observations |
| Belize. National Drug Formulary | 12.06 Lipid-lowering agents | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 02.12 Lipid-Regulating Drugs | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 12.6. Lipid-lowering agents |
Others observations: For use in high-risk patients. This medicine has the best evidence for effectiveness and safety. |
| Peru | 12.6 Hypolipidemiants | No observations |
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Cvs Anti-Arrhythmic Drugs | No observations |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 1.11.2 Statins | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | C. APARELHO CARDIOVASCULAR | No observations |
| Suriname. NGK-C-011 | 12.6 Lipid Lowering Agents | No observations |
| Haiti. National List of Essential Medicines | 12.06. Hypolipidemics | No observations |
| Bahamas. Drug Formulary | 02. CARDIOVASCULAR DRUGS | No observations |